Revised diagnostic criteria for Alzheimer’s Published
New diagnostic criteria for Alzheimer’s presented at the Clinical Trials on Alzheimer’s Disease Conference in Madrid on behalf of International Working Group
New diagnostic criteria for Alzheimer’s presented at the Clinical Trials on Alzheimer’s Disease Conference in Madrid on behalf of International Working Group
Dr Russell Chander is a Postdoc Researcher at the Centre for Healthy Brain Ageing, UNSW working on clinical and neuroimaging biomarkers for vascular dementia
Professor Diego Forero works at Fundación Universitaria del Área Andina in Columbia, his work is focussed on researching human genetics and genomics
Bernie McInally highlights the overlooked LGBTQ+ population in care homes, stressing the need for inclusivity in research to enhance future care and support.
Aitana Sogorb Esteve hosts Charlie Arber & Sam Crawford discussing stem cell research and insights into rare familial British dementia and Race Against Dementia
Dr Rosie Jackson is a Principal Investigator at University of Dundee exploring the impact of ApoE on the brain in health and disease.
Dr Patricia Kelly is a Research Scientist at Ulster University working on Alzheimer’s using animal models and advanced microscopy.
Dr Jodi Watt blog, exploring the creation of dementia-friendly spaces that empower and support—simple changes can enhance safety, independence, and comfort
NICE says evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.
Highlights from the Lausanne XI Conference – ideas, diverse perspectives, and deep expertise from prevention to treatments.
Dr Jenna Merenstein is a Postdoctoral Scholar at Duke University Medical Center using MRI to study healthy brain aging on cognitive abilities.
Dr Rademene Oria is a Lecturer and ISTAART Ambassador (2024/25) at University Of Cross River State exploring Neurotoxicology / Neurodegenerative disease